These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31395855)

  • 21. Anticancer effect of a curcumin derivative B63: ROS production and mitochondrial dysfunction.
    Zheng A; Li H; Wang X; Feng Z; Xu J; Cao K; Zhou B; Wu J; Liu J
    Curr Cancer Drug Targets; 2014; 14(2):156-66. PubMed ID: 24274397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ursolic acid synergistically enhances the therapeutic effects of oxaliplatin in colorectal cancer.
    Shan J; Xuan Y; Zhang Q; Zhu C; Liu Z; Zhang S
    Protein Cell; 2016 Aug; 7(8):571-85. PubMed ID: 27472952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyaluronic Acid-Zein Core-Shell Nanoparticles Improve the Anticancer Effect of Curcumin Alone or in Combination with Oxaliplatin against Colorectal Cancer via CD44-Mediated Cellular Uptake.
    Liu L; Yang S; Chen F; Cheng KW
    Molecules; 2022 Feb; 27(5):. PubMed ID: 35268597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Oxaliplatin on Human Colorectal and Gastric Cancer Xenografts.
    Nukatsuka M; Nakagawa F; Takechi T
    Anticancer Res; 2015 Sep; 35(9):4605-15. PubMed ID: 26254349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Piperlongumine rapidly induces the death of human pancreatic cancer cells mainly through the induction of ferroptosis.
    Yamaguchi Y; Kasukabe T; Kumakura S
    Int J Oncol; 2018 Mar; 52(3):1011-1022. PubMed ID: 29393418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perifosine sensitizes curcumin-induced anti-colorectal cancer effects by targeting multiple signaling pathways both in vivo and in vitro.
    Chen MB; Wu XY; Tao GQ; Liu CY; Chen J; Wang LQ; Lu PH
    Int J Cancer; 2012 Dec; 131(11):2487-98. PubMed ID: 22438101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GL-V9 synergizes with oxaliplatin of colorectal cancer via Wee1 degradation mediated by HSP90 inhibition.
    Chen H; Yang F; Zhao Q; Wang H; Zhu M; Li H; Ge Z; Zhang S; Guo Q; Hui H
    J Pharm Pharmacol; 2024 Aug; 76(8):1006-1017. PubMed ID: 38767973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Piperlongumine increases sensitivity of colorectal cancer cells to radiation: Involvement of ROS production via dual inhibition of glutathione and thioredoxin systems.
    Wang H; Jiang H; Corbet C; de Mey S; Law K; Gevaert T; Feron O; De Ridder M
    Cancer Lett; 2019 May; 450():42-52. PubMed ID: 30790679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of PGE
    Huang H; Aladelokun O; Ideta T; Giardina C; Ellis LM; Rosenberg DW
    Sci Rep; 2019 Mar; 9(1):4954. PubMed ID: 30894570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Piperlongumine induces apoptotic and autophagic death of the primary myeloid leukemia cells from patients via activation of ROS-p38/JNK pathways.
    Xiong XX; Liu JM; Qiu XY; Pan F; Yu SB; Chen XQ
    Acta Pharmacol Sin; 2015 Mar; 36(3):362-74. PubMed ID: 25619389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melatonin Promotes Apoptosis of Oxaliplatin-resistant Colorectal Cancer Cells Through Inhibition of Cellular Prion Protein.
    Lee JH; Yoon YM; Han YS; Yun CW; Lee SH
    Anticancer Res; 2018 Apr; 38(4):1993-2000. PubMed ID: 29599315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Redox-sensitive cyclophilin A elicits chemoresistance through realigning cellular oxidative status in colorectal cancer.
    Peng L; Jiang J; Chen HN; Zhou L; Huang Z; Qin S; Jin P; Luo M; Li B; Shi J; Xie N; Deng LW; Liou YC; Nice EC; Huang C; Wei Y
    Cell Rep; 2021 Nov; 37(9):110069. PubMed ID: 34852234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Andrographolide reversed 5-FU resistance in human colorectal cancer by elevating BAX expression.
    Wang W; Guo W; Li L; Fu Z; Liu W; Gao J; Shu Y; Xu Q; Sun Y; Gu Y
    Biochem Pharmacol; 2016 Dec; 121():8-17. PubMed ID: 27693317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gambogenic acid induces Noxa-mediated apoptosis in colorectal cancer through ROS-dependent activation of IRE1α/JNK.
    Zhao Q; Zhong J; Bi Y; Liu Y; Liu Y; Guo J; Pan L; Tan Y; Yu X
    Phytomedicine; 2020 Nov; 78():153306. PubMed ID: 32854039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis.
    Lu YX; Ju HQ; Wang F; Chen LZ; Wu QN; Sheng H; Mo HY; Pan ZZ; Xie D; Kang TB; Chen G; Yun JP; Zeng ZL; Xu RH
    Cancer Lett; 2016 Sep; 380(1):87-97. PubMed ID: 27322737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic anti-tumour effects of tetrandrine and chloroquine combination therapy in human cancer: a potential antagonistic role for p21.
    Mei L; Chen Y; Wang Z; Wang J; Wan J; Yu C; Liu X; Li W
    Br J Pharmacol; 2015 May; 172(9):2232-45. PubMed ID: 25521075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cells.
    Fiore D; Proto MC; Pisanti S; Picardi P; Pagano Zottola AC; Butini S; Gemma S; Casagni A; Laezza C; Vitale M; Ligresti A; Di Marzo V; Zisterer DM; Nathwani S; Williams DC; Campiani G; Gazzerro P; Bifulco M
    Cancer Biol Ther; 2016 Aug; 17(8):849-58. PubMed ID: 26392056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endoplasmic reticulum-targeting photosensitizer Hypericin confers chemo-sensitization towards oxaliplatin through inducing pro-death autophagy.
    Lin S; Yang L; Shi H; Du W; Qi Y; Qiu C; Liang X; Shi W; Liu J
    Int J Biochem Cell Biol; 2017 Jun; 87():54-68. PubMed ID: 28392376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AMPKα1 confers survival advantage of colorectal cancer cells under metabolic stress by promoting redox balance through the regulation of glutathione reductase phosphorylation.
    Wang YN; Lu YX; Liu J; Jin Y; Bi HC; Zhao Q; Liu ZX; Li YQ; Hu JJ; Sheng H; Jiang YM; Zhang C; Tian F; Chen Y; Pan ZZ; Chen G; Zeng ZL; Liu KY; Ogasawara M; Yun JP; Ju HQ; Feng JX; Xie D; Gao S; Jia WH; Kopetz S; Xu RH; Wang F
    Oncogene; 2020 Jan; 39(3):637-650. PubMed ID: 31530934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eukaryotic initiation factor 4A2 promotes experimental metastasis and oxaliplatin resistance in colorectal cancer.
    Chen ZH; Qi JJ; Wu QN; Lu JH; Liu ZX; Wang Y; Hu PS; Li T; Lin JF; Wu XY; Miao L; Zeng ZL; Xie D; Ju HQ; Xu RH; Wang F
    J Exp Clin Cancer Res; 2019 May; 38(1):196. PubMed ID: 31088567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.